Specializes in Phase I/IIa Clinical Trials and Bioequivalence Studies for pharmaceutical, biotech and medical device companies worldwide. Our 170+ bed facility, located in Toronto, Canada, includes 4 BE clinical units, a 14-bed, state-of-the-art Phase I unit and in-house Bioanalytical Lab. We also offer support services including bioioanalysis, pharmacokinetic analysis, statistical analysis, data management, technical writing, study design preparation, project management and quality assurance.